CLEAR LABELS Act
27 July 2026 | Reported by committee (Health, Education, Labor, and Pensions, with an amendment in the nature of a substitute, without written report)
What's next: Floor scheduling (leadership decides if and when it gets a vote)
Summary: The bill would require drug manufacturers to label their products with information about who originally made the active ingredients and the finished drug, as well as any packers or distributors involved. This labeling information could appear on the product itself or be made available electronically, and the FDA would have authority to penalize companies that fail to comply, though it would consider factors like whether companies were given a chance to fix violations before imposing fines.
[AI-Generated]Sign in to vote or follow
Posted 10 September 2026